Abstract: The invention relates to trazodone for use in the treatment of insomnia in the pediatric population, wherein said pediatric population is affected by an Intellectual Disability or a Neurodevelopmental Disorder. The invention also relates to pediatric formulations at a trazodone concentration comprised of from 0.1 to 4% and pediatrically suitable excipients.

Abstract: The device comprises a cabinet with atmosphere controlled by refrigeration and/or supply of an inert gas to prevent the deterioration of the foodstuffs. Present in the cabinet is an automatic storage unit with container means for containing the products. The latter are to be fed towards an automatic slicing machine which carries out controlled slicing both as regards the thickness of the slices and as regards the number of slices and the weight of the sliced product. Finally, a delivery unit makes it possible to dispense the products outside the cabinet. Operation of the device is controlled by a unit, which is accessible to the user from outside the cabinet. Said unit is preferably arranged for payment using different paying means.

Abstract: A disposable absorbent article such as a diaper is provided with a continuous upper layer, an absorbent element, an impermeable plastics sheet, elastic parts positioned along the lateral edges to either side of the absorbent element and two elasticized flaps positioned inwardly of the elastic parts. Each flap is formed out of the continuous upper layer by use of an elastic element fixed along its entire length to the inner surface of the continuous layer. The continuous upper layer is liquid-permeable in the zone between the two elastic elements of the flaps and impermeable in the two adjacent zones located between the elastic elements and the lateral edges of the absorbent article.

Abstract: Alkyl derivatives of trazodone endowed with pharmacological activity, pharmaceutical compositions containing them, process for preparing them and intermediate compounds useful in their preparation are disclosed.

Abstract: Glycogen polysaccharides substantially free of nitrogenous compounds and reducing sugars.

Abstract: A synthesis is described for the preparation of cationic polymer materials with a semisynthetic matrix, having superabsorption characteristics towards water and saline solutions. More particularly, cellulose cationic derivatives are described, having superabsorption characteristics, which are obtained starting from cellulose substrates which are reacted with an excess of quaternary ammonium compound in an alkaline medium.

Abstract: Alkyl derivatives of trazodone endowed with pharmacological activity, pharmaceutical compositions containing them, process for preparing them and intermediate compounds useful in their preparation.

Abstract: Polymeric polyetheramidoamine hydrogel materials, which are capable of complexing heparin in physiological conditions are herein described. Said materials are useful in the manufacturing of medical devices.

Abstract: Glycogen polysaccharides substantially free of nitrogenous compounds and reducing sugars.

Abstract: Polyetheramidoamine hydrogels consisting of polyetheramidomaine and/or polyamidoamine prepolymers crosslinked by Michael's nuceophilic polyaddition with alpha-omega-diamino monomers or with alpha-omega-diamino monomers or oligomers; said hydrogels having a swelling degree in water higher than 500% and are useful as superabsorbent materials.

Abstract: Alkyl derivatives of trazodone endowed with pharmacological activity, pharmaceutical compositions containing them, process for preparing them and intermediate compounds useful in their preparation.

Abstract: A pharmaceutical composition for the treatment of autoimmune diseases comprising an effective amount of a compound of formulaA--CH.sub.2 --O--CRR'--COOR"' (I)whereA is the nucleus of 1-benzyl-indazol-3-yl,R and R', the same or different from each other, are H or an alkyl having from 1 to 5 carbon atoms,R"' is H or an alkyl having from 1 to 4 carbon atoms,or, when R"' is H, of a salt thereof with organic or inorganic pharmaceutically acceptable bases.